Search
Site Sections

U.s. Trade Rep Urged Not To Sanction Countries If They Sidestep Patents On Vertex Cystic Fibrosis Drugs Вђ“ Mr Validity ✅

Advocacy groups are urging the U.S. Trade Representative (USTR) not to sanction South Africa, India, Ukraine, and Brazil for attempting to bypass Vertex Pharmaceuticals' patents on the high-cost cystic fibrosis drug Trikafta. The coalition argues that public health needs, addressed through potential compulsory licensing for cheaper generics, should supersede patent enforcement, citing high international prices. For more details, visit STAT News .

U.S. Trade Rep urged not to sanction countries if they sidestep patents on Vertex cystic fibrosis drugs – Mr Validity
Base Media

Copyright © 2000 - 2026 Base Media. All Rights Reserved. Console Database is a trademark of Base Media. Designated trademarks and brands are the property of their respective owners. Use of this Web site constitutes acceptance of the Base Media User Agreement and Privacy Policy. Our other sites: Deals United - Daily Deals Aggregator and WhichPlug? - Travel Adaptor Finder.